The growing global community of people who are independently pursuing Press/Pulse protocol do demonstrate, albeit anecdotally, that perhaps even imperfect implementation of adjuvant metabolic therapies can produce measurable and meaningful clinical results, in the form of statistically significant increases in Overall Survivorship as evidenced by PET/CT scans and MRIs, in contrast to only Standard of Care therapies, via comparison to known Kaplan-Meier survivorship curves for any given Standard of Care protocol.
Given that the Oncology market (cancer diagnostics and treatments) in the United States is projected to increase from $81B in 2024 to $180B in 2033, this begs the question: what is the scale of underwriting and funding, along with private and philanthropic investment, that would have to occur for the clinically managed application of Dr. Seyfried’s Press/Pulse protocol, to sufficiently scale to begin to preempt the deaths from cancer of 700,000 people annually?
Relatedly, what is the most expeditious means of training Oncologists, and more broadly, Functional or Complementary Medicine physicians, D.O.s and Naturopaths, to effectively apply Press/Pulse protocol in their clinics, as an adjuvant therapy in context to the Standard of Care?
And lastly, who will be the first entrepreneur to create a successful global franchise of Press/Pulse clinics which offer the entire balance of metabolic therapies alongside the Standard of Care, all under one roof?
As with all revolutions, be they medical or social, they are typically initiated in modest fashion, by a relatively small group of people, in solidarity, coalescing and collaborating around a single, inescapable idea.
Survive.